| Fry's Food And Drug Store #104 | |
| 201 N Switzer Canyon Dr, Flagstaff, Arizona 86001 | |
| (928) 774-3389 |
| Name | Fry's Food And Drug Store #104 |
|---|---|
| Organization Name | Smiths Food & Drug Centers Inc |
| Location | 201 N Switzer Canyon Dr, Flagstaff, Arizona 86001 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (928) 774-3389 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The 3rd Annual BioPartnering China conference, co-produced by TVG and the Zhangjiang Biotech Pharmaceutical Base, launched today at the Renaissance Shanghai Pudong Hotel. The conference attracts a global representation of industry leaders from China, Europe and the USA.
Established in 2007 and based in Toronto, ArcticDx has developed a test, Macula Risk-, the first of its kind and specifically designed to determine one's inherited risk for age-related macular degeneration (AMD), the most common form of acquired blindness in the developed world, affecting over 10% of individuals. ArcticDx will use the PBDF investment to undertake studies in support of a planned filing for Food and Drug Administration (FDA) approval for Macula Risk.
Dendritic cells, known to be the prime movers of the body's immune response, are still notoriously difficult to study in humans. Samples, which come primarily from bone marrow or lymphoid tissue, are simply too difficult to obtain. But new research at Rockefeller University has shown scientists a way to study "authentic" dendritic cells from mouse monocytes, which are abundant in the blood, a much more accessible source in humans.
U.S. hospitals wait over a year on average to begin prescribing newly developed antibiotics, a delay that might threaten the supply or discourage future development of needed drugs.
As the summer comes to a close, I wanted to update you on the Company's accomplishments this year, which set the stage for an exciting fall. The first eight months of the year have been very successful, with the Company attaining many of its goals, despite a very difficult economic environment, which has created challenges for many small biotechnology companies. Today, IMUC is in its best financial position ever and well positioned to validate the success it achieved in a Phase I trial for ICT-107, its dendritic cell-based cancer vaccine product candidate.
› Verified 3 days ago
| NPI Number | 1831131366 |
| Organization Name | SMITHS FOOD & DRUG CENTERS INC |
| Doing Business As | FRYS FOOD AND DRUG |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 201 N Switzer Canyon Dr, Flagstaff, AZ 86001 |
| Phone Number | 928-774-3389 |
News Archive
The 3rd Annual BioPartnering China conference, co-produced by TVG and the Zhangjiang Biotech Pharmaceutical Base, launched today at the Renaissance Shanghai Pudong Hotel. The conference attracts a global representation of industry leaders from China, Europe and the USA.
Established in 2007 and based in Toronto, ArcticDx has developed a test, Macula Risk-, the first of its kind and specifically designed to determine one's inherited risk for age-related macular degeneration (AMD), the most common form of acquired blindness in the developed world, affecting over 10% of individuals. ArcticDx will use the PBDF investment to undertake studies in support of a planned filing for Food and Drug Administration (FDA) approval for Macula Risk.
Dendritic cells, known to be the prime movers of the body's immune response, are still notoriously difficult to study in humans. Samples, which come primarily from bone marrow or lymphoid tissue, are simply too difficult to obtain. But new research at Rockefeller University has shown scientists a way to study "authentic" dendritic cells from mouse monocytes, which are abundant in the blood, a much more accessible source in humans.
U.S. hospitals wait over a year on average to begin prescribing newly developed antibiotics, a delay that might threaten the supply or discourage future development of needed drugs.
As the summer comes to a close, I wanted to update you on the Company's accomplishments this year, which set the stage for an exciting fall. The first eight months of the year have been very successful, with the Company attaining many of its goals, despite a very difficult economic environment, which has created challenges for many small biotechnology companies. Today, IMUC is in its best financial position ever and well positioned to validate the success it achieved in a Phase I trial for ICT-107, its dendritic cell-based cancer vaccine product candidate.
› Verified 3 days ago
News Archive
The 3rd Annual BioPartnering China conference, co-produced by TVG and the Zhangjiang Biotech Pharmaceutical Base, launched today at the Renaissance Shanghai Pudong Hotel. The conference attracts a global representation of industry leaders from China, Europe and the USA.
Established in 2007 and based in Toronto, ArcticDx has developed a test, Macula Risk-, the first of its kind and specifically designed to determine one's inherited risk for age-related macular degeneration (AMD), the most common form of acquired blindness in the developed world, affecting over 10% of individuals. ArcticDx will use the PBDF investment to undertake studies in support of a planned filing for Food and Drug Administration (FDA) approval for Macula Risk.
Dendritic cells, known to be the prime movers of the body's immune response, are still notoriously difficult to study in humans. Samples, which come primarily from bone marrow or lymphoid tissue, are simply too difficult to obtain. But new research at Rockefeller University has shown scientists a way to study "authentic" dendritic cells from mouse monocytes, which are abundant in the blood, a much more accessible source in humans.
U.S. hospitals wait over a year on average to begin prescribing newly developed antibiotics, a delay that might threaten the supply or discourage future development of needed drugs.
As the summer comes to a close, I wanted to update you on the Company's accomplishments this year, which set the stage for an exciting fall. The first eight months of the year have been very successful, with the Company attaining many of its goals, despite a very difficult economic environment, which has created challenges for many small biotechnology companies. Today, IMUC is in its best financial position ever and well positioned to validate the success it achieved in a Phase I trial for ICT-107, its dendritic cell-based cancer vaccine product candidate.
› Verified 3 days ago
Cvs Pharmacy #09231 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3506 E Route 66, Flagstaff, Arizona 86004 Phone: (928) 526-6506 | |
Cvs Pharmacy #16354 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1650 S Milton Rd, Flagstaff, Arizona 86001 Phone: (928) 779-2661 | |
Lincare Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 460 N Switzer Canyon Dr, Flagstaff, Arizona 86001 Phone: (928) 779-2886 | |
Rotech Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2355 N Steves Blvd, Flagstaff, Arizona 86004 Phone: (928) 289-5137 | |
Walgreens #5221 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1025 S Milton Rd, Flagstaff, Arizona 86001 Phone: (928) 779-9588 |